Finance

Lists
Q3 2026 earnings • released • EPS beat +33.33%
See results
ANVS:NYSE
Annovis Bio Inc
$0.93
+9.44%
(+0.080) 1D
$0.92
-0.48% (-0.0044)
After hours
Closed: Nov 13, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
$0.88
High
$0.95
Low
$0.81
Mkt. cap
57.25M
Avg. vol.
2.41M
Volume
2.20M
52-wk high
$5.50
52-wk low
$0.62
EPS
-$1.78
Beta
1.36
Shares outstanding
42.68M
No. of employees
8
Open
$0.88
High
$0.95
Low
$0.81
Mkt. cap
57.25M
Avg. vol.
2.41M
Volume
2.20M
52-wk high
$5.50
52-wk low
$0.62
EPS
-$1.78
Beta
1.36
Shares outstanding
42.68M
No. of employees
8
News stories
From web sources and news partners
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Websiteannovisbio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current $0.93
$17.00 (+1,735.65%)
Average
$10.67 (+1,052.14%)
Lowest
$7.00 (+655.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+763.8%
10/22/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$7.00
+655.9%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$17.00
+1,735.7%
08/18/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$8.00
+763.8%
07/07/2026
Last report
Nov 13, 2026
Fiscal period
Q3 2026
-$0.22 / -$0.33
+33.33%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.29M
8.75M
16.72M
12.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
955.15K
1.19M
2.37M
Operating expense
7.43M
9.71M
17.91M
14.38M
Total operating expenses
7.43M
9.71M
17.91M
14.38M
Operating income
-7.43M
-9.71M
-17.91M
-14.38M
Other non operating income
20.00K
-296.00K
268.00K
-603.34K
EBT including unusual items
-7.26M
-9.83M
-17.61M
-14.82M
EBT excluding unusual items
-7.26M
-9.83M
-17.51M
-14.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.26M
-9.83M
-17.61M
-14.82M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.39
-0.63
-0.40
Interest and investment income
152.32K
167.74K
137.80K
160.23K
Interest expense
-
-
-
-
Net interest expenses
152.32K
167.74K
137.80K
160.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps